Calidi Biotherapeutics, Inc. CLDI
0.77 USD +0.02 (+2.75%)
Nov 4, 2026, 1:44 PM EST
0.6503 Day range 0.792
0.62 52-week range 27.04
- YTD
- -95.89%
- 1 year
- -96.79%
Analyst view
Price target (mean) 6.25 +712.1% upside
Now 0.7696
- Target (low)
- 2.50
- Target (mean)
- 6.25
- Target (high)
- 10.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 27, 2024 | Ladenburg Thalmann | Initiated | — | Buy |
| May 15, 2024 | Baird | Maintained | Outperform | Outperform |
| Mar 21, 2024 | Baird | Maintained | Outperform | Outperform |
| Mar 21, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 22, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 9, 2023 | Baird | Initiated | — | Outperform |